Melanoma Uveal
Mostrando 13-24 de 73 artigos, teses e dissertações.
-
13. Braquiterapia com rutênio-106 em melanomas uveais - resultados preliminares: experiência uni-institucional
OBJETIVO: Analisar os resultados preliminares da braquiterapia com rutênio-106 em pacientes portadores de melanomas uveais. MATERIAIS E MÉTODOS: No período de abril de 2002 a julho de 2003, 20 pacientes com diagnóstico de melanoma uveal foram tratados com braquiterapia com rutênio-106. A dose calculada no ápice tumoral variou de 55 Gy a 100 Gy. Pacient
Radiologia Brasileira. Publicado em: 2007-04
-
14. Aspectos psicológicos e qualidade de vida em pacientes com melanoma uveal durante o processo de tratamento por remoção do bulbo ocular
OBJETIVO: Avaliar prospectivamente as repercussões emocionais no indivíduo com melanoma uveal e indicação cirúrgica em três momentos: diagnóstico e pré-cirúrgico, pós-cirúrgico e pós-cirúrgico tardio. MÉTODOS: Trata-se de estudo clínico-qualitativo, no qual se utilizaram os seguintes instrumentos: Inventário de Ansiedade Traço/Estado - IDATE
Arquivos Brasileiros de Oftalmologia. Publicado em: 2006-12
-
15. Braquiterapia com Cobalto 60 para o tratamento do melanoma da úvea: análise dos fatores prognósticos para melhor resposta local
Objetivo: Determinar fatores prognósticos para resposta tumoral local ao tratamento do melanoma uveal por braquiterapia com cobalto 60, segundo parâmetros clínicos e próprios deste método. Métodos: Avaliamos os índices de controle tumoral, complicações, doença metastática e sobrevida global em 69 portadores de melanoma uveal tratados por braquiter
Arquivos Brasileiros de Oftalmologia. Publicado em: 2002-03
-
16. Bilateral ocular melanocytosis with malignant melanoma of the choroid.
A woman with bilateral ocular melanocytosis developed a malignant melanoma of the choroid in one eye. The ocular melanotic hyperpigmentation, present since childhood, clinically involved the conjunctiva and episcleral and uveal tract of both eyes. To our knowledge this is only the second reported case of a uveal malignant melanoma in a patient with bilateral
-
17. Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.
BACKGROUND--Uveal melanoma is a tumour with a high incidence of metastasis and a high mortality rate. Additional therapies to obtain a better local control or an effective treatment of metastases are necessary. Interferons may be applied. METHODS--The effects of human interferon alfa and gamma on proliferation and expression of immunologically important mole
-
18. Accuracy of presumed uveal melanoma diagnosis before alternative therapy.
AIMS/BACKGROUND--This study was performed to ascertain the diagnostic accuracy rate of non-invasive tests in patients with presumed uveal melanomas scheduled to be treated with either irradiation or cyclochoroidectomy. METHODS--One hundred consecutive patients who had non-invasive tests followed by fine needle aspiration biopsy (FNAB) as prior alternative tr
-
19. Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
Tests of cell mediated immunity (one and two stage leucocyte migration inhibition assays) and humoural immunity (membrane immunofluorescence and serum effects on leucocyte migration) were done with leucocytes and sera from 36 patients with uveal melanoma, five with conjunctival melanoma, 21 with non-malignant ocular disease, and 189 with cutaneous melanoma.
-
20. Familial uveal melanoma.
The cause of uveal melanoma is unknown. In a few cases, however, factors are found in association with the disease which may play some part in the aetiology. One such factor is inheritance. Twelve families have been reported with adequate documentation during the last century in which two or more members have had uveal melanomas. At least some of these may b
-
21. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.
The possibility of using radiolabelled monoclonal antibody fragments to image uveal melanomas has been assessed in a pilot study. 99mTc labelled F(ab')2 fragments of MoAb 225.28S raised against cutaneous melanomas were used. Initially 10 patients were imaged. In five patients the clinical findings were typical of uveal melanoma. Immunoscintigraphy was positi
-
22. Uveal malignant melanoma and optic nerve glioma in von Recklinghausen's neurofibromatosis.
A case of uveal malignant melanoma and contralateral optic nerve glioma is described in a 53-year-old Caucasian male with multiple uveal melanocytic hamartomas and neurofibromatosis. The eye was enucleated, and histologically the melanoma was found to consist of 70% epithelioid cells, with many bizarre, multinucleated forms. CT scan demonstrated a non-enhanc
-
23. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates.
Two hundred and twenty-three patients treated by cobalt plaque for uveal melanoma were compared with 416 patients treated by enucleation for uveal melanoma in terms of patient survival. The median follow-up time for the patients treated by cobalt plaque was 4.3 years. Kaplan-Meier survival curves were calculated up to five years following treatment based on
-
24. Ultrasonographic measurement of uveal melanoma thickness: interobserver variability.
We retrospectively reviewed ultrasonographic data on 32 uveal melanomas that had been studied both at a referral institution and at our centre within a six-week period. Generally there were good correlations between ultrasonographic measurements of tumour thickness. The mean absolute difference in ultrasound measurements of tumour thickness was 0.64 mm (rang